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7.1 Introduction
Despite of improvements and better quality of organ preservation due to the Uni-
versity of Wisconsin (UW) solution and similar cold storage (CS) solutions, which
were subsequently developed following the UW concept, organ preservation has re-
mained an Achilles heel of transplantation. Due to the persistent shortage of donor
organs nowadays older and more marginal donor livers are accepted for transplan-
tation by most centres. This results in less organ viability and a higher chance of
early dysfunction with lower graft survival after transplantation. Thus, to main-
tain or even improve organ viability during preservation and reduce the effect of
ischemia/reperfusion injury another mode of preservation has become mandatory.
Hypothermic machine preservation (HMP) is a method of organ preservation in
89
7. Comparison of Oxygenators
which, in contrast to the CS technique, the donor organ is continuously perfused
with the preservation solution under hypothermic conditions, allowing continuous
supply of nutrients and removal of waste products. In the past HMP has been suc-
cessfully applied in kidney transplantation with improved clinical results in com-
parison to CS7,8,9. Thus, we assumed that HMP would be beneficial for the liver
as well. This assumption was supported by experimental work in the eighties by
Belzer and Southard’s group10,11.















HydroxyEthyl Starch 50 [g/l]
Table 7.1: Composition of the Belzer University of Wisconsin machine preservation
solution (UW-MP).
tion wether adding oxygen to the Belzer University of Wisconsin machine preser-
vation solution (UW-MP)is necessary or not (Table 7.1). During his experiments,
Pienaar et al10 did not use any additional oxygen, and achieved a 90% short term
survival after 72 hrs HMP of dog livers. In his experiments the follow-up, however,
was only 14 days and no long-term results could be obtained due to the design of
the study, including thus the possibility of ischemia type biliary lesions or other
late graft dysfunction due to lack of oxygen which would require retransplantation
in clinics. On the other hand, Dutkowski et al12,13 argued, that it is beneficial to
actively include oxygen during preservation. Fujita et al14,15 came to a similar con-
clusion, when they determined the oxygen consumption (V O2) during continuous
perfusion of rat livers as a function of temperature (T ) [◦C]: V O2 = 0.21 · 100.029·T
[mmol/min/gr liver]. Oxygen consumption at 0◦C is 0.21 mmol/min/g liver, which
is, compared to oxygen consumption of the liver at 37◦C, a twelve-fold decrease.
A rat liver slice study, performed recently by our group, reconfirmed that oxygen
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supply during preservation is indeed important and should be included during HMP
with UW-MP solution16.
Thus, in our attempt to develop a portable HMP system in which donor livers are
stored and can be easily transported, we decided that it was necessary to include
an oxygenation facility to fulfil the need of oxygen during HMP. Data of oxygenator
performance under hypothermic conditions (0-4◦C) or when an a-cellular preser-
vation solution such as UW-MP (Table 7.1) is used is lacking in the literature.
The aim of this study was therefore to compare commercially available miniature
oxygenators for their ability to sufficiently oxygenate the UW-MP solution. Addi-
tional criteria were a low pressure drop and small dimension to be able to fit the
oxygenator in the portable HMP system.
7.2 Materials and Methods
Four types of commercially available miniature hollow fibre gas exchangers were
selected based on size and cost and were evaluated for the use in a hypothermic
liver machine perfusion system. In addition to the specifications listed in Table
7.2, the gas exchangers and a number of specific features are discussed below.
HILITE Baby-RX MiniModule FiberFlo
Diameter 55 mm 87 mm 27 mm 25.5 mm
Length 150 mm 130 mm 195 mm 175 mm
Build-in vol. 3495 mm3 3809 mm3 3183 mm3 2776 mm3
Area 3200 cm2 5000 cm2 1200 cm2 2300 cm2
Priming vol. 50 ml 43 ml 10 ml 15 ml
Price e600 e550 e140 e100
Flow range 0-1 l/min 0-2.5 l/min 0-1 l/min 0-3 l/min
∆P 0-70 mmHg 0-190 mmHg 0-233 mmHg 0-520 mmHg
Type 800 LT Capiox RX05 0.75×5 MV-C-030-L
Manufacturer MEDOS Terumo, Membrana Minntech
Medizintechnik, Tokyo, Jpn Celgard, Fibercor
Stolberg, D Charlotte, USA Minneapolis, USA
Table 7.2: The tested oxygenators with their geometric and physical properties,
price and type and manufacturer details.
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The following gas exchangers were evaluated:
HILITE The HILITE infant hollow fibre oxygenator (HILITE 800LT, MEDOS
Medizintechnik AG, Stolberg, Germany) is designed for extracorporeal blood-
gas exchange for infants. Special features of the 800LT version are the inte-
grated heat exchanger and the plasma-tight hollow fibre membranes (poly-
methylpentene) that make the oxygenator especially useful for long term
applications.
Baby-RX The Baby-RX (CAPIOX RX05, Terumo, Tokyo, Japan) oxygenator is
developed for blood oxygenation of neonates and infants during extracorpo-
real circulation. The oxygenator has a low priming volume yet a large flow
range. The design combines an integrated heat exchanger with compact outer
dimensions.
MiniModule The MiniModule (Liqui-Cel MiniModule 0.75x5, Membrana, Char-
lotte, USA) is a membrane gas exchanger of polypropylene fibres. It is de-
veloped for degassing aqueous fluids by a vacuum or strip gas stream around
the fibres. There is no FDA approval for contact with blood. However, since
liver HMP uses UW-solution, gas exchange with this type of exchanger could
be applicable.
FiberFlo The FiberFlo gas exchanger (MV-C-030-L, Minntech Fibercor, Min-
neapolis, USA) includes a hydrophobic polypropylene hollow fibre. It is orig-
inally developed for gas removal from fluids, but filtration and oxygenation
are possible applications as well.
7.2.1 Experimental set-up
The measuring set-up to test the different gas exchangers consists of a reservoir,
a rotary pump (Deltastream, MEDOS Medizintechnik AG, Stolberg, Germany), a
de-oxygenator (Lilliput, Sorin/Dideco, Mirandola, Italy) and the test oxygenator
(Figure 7.1). The UW-MP preservation solution (Table 7.1) is cooled with melting
ice to maintain a temperature of 0◦C. A 100% nitrogen stream at maximum flow
rate through the de-oxygenator was used to de-oxygenate the solution.
The capacity of the tested oxygenator is determined by measuring the pO2 [kPa]
difference between the inlet and outlet of the oxygenator. For this purpose, 0.5
ml samples of the perfusate are taken and analysed in a blood gas analyser (ABL
700, Radiometer A/S, Brønshøj, Denmark). To determine the pressure drop (∆ P)
[mmHg] over the test oxygenator, the difference between inlet and outlet pressure
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was measured with pressure transducers (Truwave, Edwards Lifesciences, Irvine,
USA). Flow was measured after the pump using an ultrasonic clamp-on flow probe
(H7C, Transonic Systems, Ithaca, USA).
Figure 7.1: The test circuit wih the de-oxygenator, test oxygenator, reservoir, pump
and measuring points (P=pressure sensor, pO2=sampling for partial oxygen pres-
sure, Q=flow sensor).
The test oxygenators were subjected to an UW-MP flow of 250, 500 and 1000
ml/min, representing the range of expected flow rates in the liver HMP system.
100% oxygen was used. At each fluid flow rate, a ratio fluid flow:oxygen flow of
2:1, 1:1 and 1:2 was established. At each fluid flow rate and ratio, partial oxygen
pressure (pO2) [kPa] and perfusion pressure (P) [mmHg] were measured at the inlet
and outlet of the test oxygenator. The measurements were performed according to
AAMI/ISO standards17, using 0◦C UW-MP solution instead of 37◦C bovine blood.
7.2.2 Error discussion
According to specifications, the inaccuracy of the pressure transducers was < 2
mmHg, of the pO2 measurements with the blood gas analyser < 1 kPa and of
the flow measurements < 7%. Values of measured pressure drop [mmHg] and
oxygenation capacity [kPa] were assumed to be different for differences larger than
the measured value ±2× inaccuracy.
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7.3 Results
The HILITE oxygenator showed an oxygenation capacity of 90 kPa at a fluid
flow rate of 250 ml/min, regardless of the fluid/gas flow-ratio (Figure 7.2a). The
capacity decreased with increasing fluid flow to 83 kPa at 500 ml/min and 68
kPa at 1000 ml/min. Again, the fluid/gas flow-ratio showed no influence at these
higher flow rates.
The Baby-RX showed an oxygenation capacity of 72.7 kPa at 250 ml/min and
a ratio of 2:1, while it was higher for the 1:1 and 1:2 ratios, 91.3 kPa and 88.6
kPa, respectively (Figure 7.2b). With increasing flow rates, oxygenation capacity
decreased to 75 kPa. No clear capacity difference was found between the ratios at
flow rates of 500 ml/min and 1000 ml/min.
Figure 7.2: Oxygenation capacities of the test oxygenators (a=HILITE, b=Baby-
RX, c=MiniModule, d=FiberFlo) at fluid flow rates of 250, 500 and 1000 ml/min
and fluid flow/gas flow-ratios of 2:1, 1:1 and 1:2. (* = not measured).
At a flow rate of 250 ml/min, the MiniModule showed an increased capacity
for a fluid/gas-ratio of 1:1 and 1:2, 60.1 kPa and 62.2 kPa, respectively, compared
to a ratio of 2:1, which is 56.1 kPa (Figure 7.2c). At 500 ml/min the capacity was
lower for each fluid/gas flow-ratio, 43 kPa for 2:1, 39.5 kPa for 1:1 and 38.6 kPa
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for 1:2. Given the high pressure drop of the Minimodule, the rotary pump used
was not able to produce a flow of 1000 ml/min through the oxygenator, so, no
measurements of oxygenation capacity at this flow rate could be obtained.
The FiberFlo, finally, had a capacity of 64.8 kPa at 250 ml/min fluid flow and
a ratio 2:1 (Figure 7.2d). Capacity increased to 75.7 kPa for 1:1, but decreased
again for 1:2 to 69.6 kPa. At a flow rate of 500 ml/min the oxygenation capacity
decreased for every ratio, 55.1 kPa, 48.7 kPa and 48.8 kPa for 2:1, 1:1 and 1:2,
respectively.
The HILITE and Baby-RX showed the highest oxygenation capacity for a fluid/gas
flow-ratio of 1:1 using flow rates of 250 ml/min, 500 ml/min and 1000 ml/min,
respectively. The capacity of the FiberFlo was lower and the MiniModule showed
the lowest (Figure 7.3).
Figure 7.3: Comparison of oxygenation capacity between the test oxygenators at
flow rates of 250, 500 and 1000 ml/min at a fluid flow/gas flow-ratio of 1:1. (* =
not measured).
Pressure drop was lowest in the two oxygenators (HILITE and Baby-RX)
compared to the two gas exchangers (MiniModule and FiberFlo) over the total flow
range (Figure 7.4). For the HILITE the pressure drop ranged from 12.8 mmHg at
250 ml/min to 69.3 mmHg at 1000 ml/min. Pressure drop in the Baby-RX ranged
from 19.2 mmHg at 250 ml/min to 94.9 mmHg at 1000 ml/min. Pressure drop
in the MiniModule could only be measured at a flow rate of 250 ml/min and was
176.1 mmHg. At higher flow rates the pressure exceeded the limits of the pressure
transducer (>200 mmHg). This was also the case for the FiberFlo at flow rates
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500 ml/min and 1000 ml/min, at 250 ml/min the pressure drop was 142.7 mmHg.
The de-oxygenator established a mean partial oxygen pressure of 14.6 kPa at the
efferent side of the test oxygenator.
Figure 7.4: Pressure drop over the test oxygenators at fluid flow rates of 250, 500
and 1000 ml/min. (* = too high to measure).
7.4 Discussion
It is our aim to develop a portable hypothermic liver perfusion system that allows
better and longer preservation than with CS while maintaining liver viability. Such
a device would allow the use of marginal, older and even non-heart-beating donor
livers and could contribute to the expansion of the donor liver pool, reducing organ
shortage. The necessity of oxygen supply in a HMP system has been indicated
in several experiments12−16. To fulfill the need for oxygen in a preserved liver at
0-4◦C hollow fibre oxygenators may be suitable. As oxygenators are not specified
for oxygenation of an a-cellular electrolyte solution such as the UW-MP preserva-
tion solution at 0-4◦C, four commercially available hollow fibre gas exchangers were
tested for use in hypothermic liver perfusion. The oxygenators were selected on the
basis of their dimensions, cost and fluid flow rate of 0-1000 ml/min (Table 7.2).
Our comparison of oxygenation capacity showed a better functioning of the HILITE
and Baby-RX than the Minimodule and FiberFlo (Figure 7.2 and 7.3). The Fiber-
Flo exceeded the Minimodule in capacity with 15 kPa at 250 ml/min and 9 kPa
at 1000 ml/min. Whether the capacity of the tested oxygenators is sufficient for
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additional oxygen support in HMP depends on the established flow rate during
perfusion. The necessary partial oxygen pressure to fulfil the oxygen consumption
of the liver, as determined by Fujita et al14, can be expressed as a function of fluid
flow rate:
pO2 =
V O2 ·H · Vmol
Q
[Pa] (7.1)
where Q is the normalised flow in ml/min/gr liver, H is Henry’s constant, denoting
the solubility of oxygen in water and Vmol is the volume of 1 mol water (=18 ml)18.
This relation is visualised in Figure 7.5 for the range of human liver weight of 1400-
1800 gr19,20,21 at 0◦C, Henry’s constant of 2.58 ·109 Pa and an oxygen consumption
of 0.21 mmol/min/gr liver. For each flow rate and fluid/gas flow-ratio, the oxygena-
tion capacity of the test oxygenators is also shown in Figure 7.5. Figure 7.5 shows
Figure 7.5: Comparison of oxygenation capacities of the test oxygenators at fluid
flow rates of 250, 500 and 1000 ml/min and fluid flow/gas flow-ratios of 2:1 (1), 1:1
(2) and 1:2 (3). Required oxygen supply for a 1400-1800gr liver at 0◦C according
to Fujita et al10 as a function of flow is shown as a grey area.
that at low fluid flow rates the MiniModule is not able to oxygenate the UW-MP
sufficiently since the capacity lies beneath the pO2 demand range. The FiberFlo
oxygenator lies just inside the pO2 demand range, the HILITE and Baby-RX have
a clear over-capacity. For increasing flow rates all oxygenators are able to satisfy
the required pO2, as measured by Fujita14, although the large difference in efficacy
between the HILITE and Baby-RX in comparison to the MiniModule and FiberFlo
remains.
An estimation of the required flow rates in the liver HMP system was based on
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physiologic pressure and flow relations in the orthotopic human liver. For the hep-
atic artery a mean pressure of 100 mmHg and a mean flow of 500 ml/min and for
the portal vein a mean pressure of 12 mmHg and a mean flow of 1000 ml/min can
be assumed22. As a consequence of the viscosity of UW-MP which is 3 times higher
compared to blood23, perfusion with UW-MP preservation solution yields a 3 times
lower flow (at the same pressure). To prevent flow-induced injury under hypother-
mic conditions a lowered perfusion pressure is used and flow rates of approximately
100 ml/min and 300 ml/min for the hepatic artery and portal vein, respectively,
are expected. At these flow rates, both the HILITE and Baby-RX are able to fulfil
the oxygen demand of the liver (Figure 7.5).
To enable the development of a portable perfusion system, it is of crucial importance
to minimise the weight, and use only a limited number of batteries and lightweight
pumps. This means that the pressure drop over the oxygenator has to be as low as
possible, and result in the necessity of small and little energy consuming pumps.
Our comparison of the four oxygenators showed that there was a large difference in
pressure drop. The HILITE and Baby-RX showed a low and acceptable pressure
drop (12.8-69.3 mmHg and 19.2-94.9 mmHg, respectively), while the MiniModule
and FiberFlo showed a much larger pressure drop (176.1 mmHg and higher and
142.7 and higher, respectively). For increasing flow, the measured efferent pres-
sures of the MiniModule and FiberFlo were higher than 200 mmHg, the maximal
measuring pressure of the probe. As a consequence, the HILITE and Baby-RX
are both suitable for the HMP system, with the HILITE having a slightly lower
pressure drop than the Baby-RX. Although the MiniModule and FiberFlo are the
lowest priced oxygenators with the smallest dimensions, the large pressure drop
and insufficient oxygenation capacity rule out their use in the HMP system. Both
the HILITE and Baby-RX are applicable in the HMP system. The Baby-RX has
the disadvantage that at a flow rate of 250 ml/min the capacity at 2:1 is less than
at 1:1 and 1:2. This means that at 250 ml/min this oxygenator works optimal at
a 1:1 or 1:2 ratio. The HILITE does not show this effect, indicating that sufficient
oxygenation is possible at an even higher fluid/gas-ratio.
In conclusion, this study shows that commercially available oxygenators, designed
for oxygenating blood at 37◦C, as well as gas exchangers designed for more indus-
trial applications, are capable of oxygenating the a-cellular UW-MP preservation
solution under hypothermic conditions (0-4◦C). The limiting factor in applying an
oxygenator in a liver HMP system is the pressure drop, which therefore should be as
low as possible. Therefor, we have selected the HILITE oxygenator for application
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